Welcome to the June edition of our Life Sciences Patents Monthly Roundup, where our global A&O Shearman team highlights key developments shaping the patent and regulatory landscape. In this month’s edition, we cover a range of developments across the UPC, the CJEU, Germany, France, and the United States.
At the Unified Patent Court (UPC), the Hamburg Local Division rules that defendants must take effective steps to ensure compliance with injunctions by third-party service providers and platforms acting on their behalf. The Düsseldorf Local Division confirms that a patentee need not practice its own invention to obtain injunctive relief and rejected a patient-interest defense in circumstances where alternative products were available on the market.